43 episodes

The Houston Healthcare Initiative (HHI) is a member owned, non-profit medical co-op. Led by Houston based neurologist Dr. Steven Goldstein, the HHI will replace traditional health insurance for qualified individuals and families and provide incentives for members to adopt healthier lifestyle habits. HHI will provide affordable medical coverage through a combination of negotiated rates, low monthly payments, personal accountability and lifestyle incentives. The medical co-op promises to save qualifying individuals and families money on health insurance. At the same time, HHI will help uphold quality care by asking members to bear some responsibility and individual accountability for maintaining their personal health.

Houston Healthcare Initiative's Podcast Harold Nicoll

    • Business
    • 5.0 • 1 Rating

The Houston Healthcare Initiative (HHI) is a member owned, non-profit medical co-op. Led by Houston based neurologist Dr. Steven Goldstein, the HHI will replace traditional health insurance for qualified individuals and families and provide incentives for members to adopt healthier lifestyle habits. HHI will provide affordable medical coverage through a combination of negotiated rates, low monthly payments, personal accountability and lifestyle incentives. The medical co-op promises to save qualifying individuals and families money on health insurance. At the same time, HHI will help uphold quality care by asking members to bear some responsibility and individual accountability for maintaining their personal health.

    November Health Insurance Selection; Which One Is Best?

    November Health Insurance Selection; Which One Is Best?

    Is it possible to get good health insurance coverage in 2021 and save money on treatments, prescription drugs and the policy too? The answer according to Dr. Steven Goldstein, founder of the Houston Healthcare Initiative and respected neurologist, is yes. Learn more about this and issues like it at www.houstonhealthcareinitiative.org.

    • 10 min
    Vaccine Development Liability Waivers Where Safety & Business Gel

    Vaccine Development Liability Waivers Where Safety & Business Gel

    There are currently 120 Coronavirus/Covid-19 vaccines in development and a race to be the first one available for the public. Being first with this vaccine will mean big rewards for the maker in the form of profits and scientific prestige. Along with these developments there is political pressure to not only be first but be first by election day. Regardless, the benefits of a vaccine for this extremely contagious virus will ultimately accrue to the public. But nothing is foolproof and there will be problems with this vaccine because there were with all of them. And when there are problems who is ultimately responsible and how can the public find justice? To know better what the possible risk benefit for a vaccine to the Covid-19 is and help us understand the possible downside and upside is respected Houston neurologist Dr. Steven Goldstein.

    • 12 min
    Who decides what medicine we can all take?

    Who decides what medicine we can all take?

    A group of U.S. doctors known collectively as the Association of American Physicians and Surgeons or the AAPS recently sued the Food and Drug Administration (FDA) for limiting use of hydroxychloroquine, and the right to prescribe hydroxychloroquine as an off-label treatment for the Coronavirus/Covid-19 virus. But there is a larger issue here that will eventually transcend the Coronavirus/Covid-19 pandemic and that is who ultimately decides what medicines we can take? Who is it that has more or less influence than they should?

    • 8 min
    Pharma: Greed Lies and the Poisoning of America

    Pharma: Greed Lies and the Poisoning of America

    On this edition we have a guest, Mr. Gerald Posner.  Mr. Posner is an accomplished investigative journalist and the author of a dozen books including “Case Closed,” a re-examination of the assassination of John F. Kennedy, and “Mengele,” an account of the botched hunt for the Nazi war criminal. His latest work is “Pharma: Greed, Lies, and the Poisoning of America.”  This book describes something we here are all very interest in which is the history of the pharmaceutical manufacturing industry. I was shocked to read that many of the practices that were incorporated into marketing and selling heroin and cocaine in the early 20th century are still used today. And like they did before, the same companies are deliberately downplaying of the risk of modern-day medicines like opioids that have led to addiction and death for so many Americans. This along with an emphasis on profits over patient well-being are included.
     

    • 44 min
    Blood Plasma Covid Treatment and Pharmaceutical Industry Reform

    Blood Plasma Covid Treatment and Pharmaceutical Industry Reform

    On August 23, 2020 the Food and Drug Administration’s announced a decision to grant blood plasma treatment for Coronavirus/Covid-19 patients with a  fast-track authorization for its emergency use as a treatment for hospitalized COVID patients. This “emergency use authorization” triggered an outcry from scientists and doctors, who said the decision was not supported by adequate clinical evidence and criticized the FDA for what was perceived as bowing to political pressure. News coverage about this potential treatment has done little to clarify whether its useful or not. The idea that there could be a motivation behind the fast track authorization for this potential treatment other than looking for a useful therapeutic is troubling. More to the point, who should decide what patients receive in treatment for their illnesses? To help us make sense of how reforms for the pharmaceutical industry could potentially help separate facts from spin and who we should all listen to is respected neurologist, Dr. Steven Goldstein.

    • 13 min
    Retractions Prove Too Late In Hydroxychloriquine (HCQ) Debate; Because No One Can Un-Ring A Bell!

    Retractions Prove Too Late In Hydroxychloriquine (HCQ) Debate; Because No One Can Un-Ring A Bell!

    Early in the pandemic, hydroxychloroquine looked like it could be a promising treatment for COVID-19 but use of the drug quickly lost favor after articles in the Lancet and New England Journal of Medicine cast doubt. Both journals retracted the articles but the damage was done. Listen to Dr. Steven Goldstein describe how and why this went wrong. 

    • 15 min

Customer Reviews

5.0 out of 5
1 Rating

1 Rating

Top Podcasts In Business